Prognostic Accuracy of Mild Cognitive Impairment Subtypes at Different Cut-Off Levels

Mattias Göthlin1, Marie Eckerström, Sindre Rolstad

  • 1Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.

Abstract

Insights

Amnestic multi-domain mild cognitive impairment (MCI) is the only subtype that accurately predicts dementia. Lowering diagnostic cut-offs for MCI impacts predictive values, highlighting its clinical utility.

Area of Science:

  • Neurology
  • Gerontology
  • Cognitive Science

Background:

  • The prognostic accuracy of mild cognitive impairment (MCI) in clinical settings is variable and debated.
  • Different criteria, cut-offs, subtypes, and follow-up durations influence MCI's predictive power for dementia.

Purpose of the Study:

  • To estimate the prognostic accuracy of MCI and its subtypes for predicting dementia.
  • To evaluate the impact of three different cut-off levels on prognostic accuracy.

Main Methods:

  • Memory clinic patients (n=317 at 2 years, n=168 at 4-6 years) were followed.
  • MCI and subtypes were categorized using 2.0, 1.5, and 1.0 standard deviations (SD) below normal control means.
  • Prognostic accuracy for dementia syndrome was estimated at follow-up.

Main Results:

  • Amnestic multi-domain MCI (aMCI-md) significantly predicted dementia across all conditions.
  • Lowering the cut-off for aMCI-md increased sensitivity and decreased specificity.
  • Non-subtyped MCI demonstrated high sensitivity but low specificity for dementia prediction.

Conclusions:

  • Amnestic multi-domain MCI (aMCI-md) is the sole viable subtype for dementia prediction in memory clinic patients.
  • Adjusting diagnostic cut-offs for aMCI-md influences predictive values, impacting clinical utility.
  • Findings clarify the prognostic utility of MCI and its role as a potentially non-progressive disorder.